Concepedia

Author

Nicholas Di Bella

Texas Oncology

Also Known As

N. Di Bella, Nicholas Di Bella

10

Publications

246

Citations

6

H-Index

18

Concepts

All Affiliations

Texas OncologyRocky Mountain Cancer CentersCancer Care NorthwestThe US Oncology Network
ND

About

Nicholas Di Bella is an author at Texas Oncology specializing in pharmacotherapy, radiation oncology, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

122

2

Health Sciences

2

2

112

3

Immunology

2

2

73

4

Molecular Medicine

1

1

10

5

Pathology

1

1

10

Nicholas Di Bella

×

6

Publications

238

Citations

6

H-Index

YearCitations

Results of a phase 2 study of bortezomib in patients with relapsed or refractory indolent lymphoma

Nicholas Di Bella, Raymond Taetle, Kathryn S. Kolibaba,

Blood

2009

77

A Phase III trial of fludarabine, cyclophosphamide, and rituximab vs. pentostatin, cyclophosphamide, and rituximab in B-cell chronic lymphocytic leukemia

Craig H. Reynolds, Nicholas Di Bella, Roger M. Lyons,

Investigational New Drugs

2011

63

Results of a Phase II Multicenter Trial of Single-Agent Gemcitabine in Patients with Relapsed or Chemotherapy-Refractory Hodgkin's Lymphoma

Hemachandra Venkatesh, Nicholas Di Bella, Thomas P. Flynn,

Clinical Lymphoma

2004

49

Phase III Trial of Fludarabine, Cyclophosphamide, and Rituximab Vs. Pentostatin, Cyclophosphamide, and Rituximab in B-Cell Chronic Lymphocytic Leukemia

Craig H. Reynolds, Nicholas Di Bella, Roger M. Lyons,

Blood

2008

28

An open‐label pilot study of pentostatin, mitoxantrone, and rituximab in patients with previously untreated, Stage III or IV, low‐grade non‐Hodgkin lymphoma

Nicholas Di Bella, Craig H. Reynolds, D Faragher,

Cancer

2005

11

An open-label, multicenter, phase II study of AT-101 in combination with rituximab (R) in patients with untreated, grade 1-2, follicular non-Hodgkin's lymphoma (FL)

Edwin Kingsley, Donald Richards, Lawrence Garbo,

Journal of Clinical Oncology

2009

10

Page 1